Literature DB >> 3921789

[Vitamin C in a long-term trial is without effect on experimental carcinogenesis].

B Werner, K Hrynyschyn, H Schäfer.   

Abstract

This long-term study deals with the effect of ascorbic acid on chemically induced carcinogenesis of the small intestine in rats. Carcinoma was induced in 27 animals by application of N-Ethyl-N'-nitro-N-nitrosoguanidine (ENNG) alone in the drinking water (120 mg/1). The average survival time was 238 ( 40) days. The addition of large amounts of ascorbic acid to the food (3 g/100 g food) did not suppress the development of tumors. On the contrary, a significant reduction in the survival time was seen. All animals receiving ENNG and ascorbic acid only lived 207 ( 45) days on average. Neither histological type of tumor spread was influenced by the use of ascorbic acid. Giving ascorbic acid alone had no effect on the survival time and did not lead to changes in the tissue of the small intestine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921789     DOI: 10.1007/bf01261292

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  14 in total

1.  [Etiology of malignant tumors].

Authors:  D Schmähl
Journal:  Wien Med Wochenschr       Date:  1975-11-07

2.  The role of ascorbic acid in the prevention of bladder tumor formation.

Authors:  J U Schlegel; G E Pipkin; R Nishimura; G N Shultz
Journal:  J Urol       Date:  1970-02       Impact factor: 7.450

3.  Influence of oral supplementation of ascorbate upon the induction of N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  H Kawasaki; F Morishige; H Tanaka; E Kimoto
Journal:  Cancer Lett       Date:  1982 May-Jun       Impact factor: 8.679

4.  High-dose methylprednisolone, vitamin A, and vitamin C in rats bearing the rapidly growing Morris 7777 hepatoma.

Authors:  I Cameron; B Grubbs; W Rogers
Journal:  Cancer Treat Rep       Date:  1979-03

5.  Relationship between ascorbic acid and cell division.

Authors:  R Liso; G Calabrese; M B Bitonti; O Arrigoni
Journal:  Exp Cell Res       Date:  1984-02       Impact factor: 3.905

6.  Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

Authors:  E T Creagan; C G Moertel; J R O'Fallon; A J Schutt; M J O'Connell; J Rubin; S Frytak
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

7.  Failure of ascorbic acid to inhibit growth of transplantable and dimethylbenzanthracene induced rat mammary tumors.

Authors:  Y J Abul-Hajj; M Kelliher
Journal:  Cancer Lett       Date:  1982-10       Impact factor: 8.679

8.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

9.  Inhibition of transplantable melanoma tumor development in mice by prophylactic administration of Ca-ascorbate.

Authors:  J M Varga; L Airoldi
Journal:  Life Sci       Date:  1983-04-04       Impact factor: 5.037

Review 10.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases.

Authors:  B N Ames
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

View more
  1 in total

1.  Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor.

Authors:  K Akhilender Naidu; Richard C Karl; Kamatham A Naidu; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.